Brandon Mancini, MD, MBA, FACRO’s Post

What exactly is Theranostics anyway? 🤔 It’s a big word, but it’s actually quite simple and fascinating. Theranostics combines Therapeutics (treatments) with Diagnostics (diagnosis), paving the way for personalized medicine. Want to learn more? This video we produced in partnership with GE HealthCare brings the concept of Theranostics to life. https://hubs.la/Q02r24Sz0 #WorldTheranosticsDay #Theranostics #PrecisionMedicine

Phaco +MIGS procedures are becoming a common choice for patients with glaucoma and cataracts. Individualised treatment goals are important but little is actually documented about this. Glaucoma Today’s article helps the clinician manage patients’ expectations by exploring how to set treatment goals

Effective #extracellularvesicle monitoring is pivotal for the future application of EV in diagnosis and therapy. Check how easy is to detect #EV using our dyes. #exosome #image #biodistribution https://lnkd.in/gAKM_Cq5

Excited to introduce #JotDyes: #ExtracellularVesicle #MembraneLabeling #Dyes! 🌟 Fluorescent probes are essential for tracking EVs in vivo, but they often pose challenges due to hydrophobicity and potential artifact formation. Here, we present JotDyes, which provides a reliable solution, avoiding false signals observed with other dyes. Utilizing JotDye-490 in vivo studies, we've unveiled the distinct accumulation pattern of #RedBloodCell-Derived EVs (#RBCEVs) in the liver and spleen. Effective EV monitoring is pivotal for the therapeutic potential of RBCEVs in conditions such as #Atherosclerosis and #Inflammation. #Biodistribution #EV #Imaging

Every journey has a beginning. If your vision is to one day scale to hundreds of billions of cells for your cell therapy, then that journey begins with the PBS Mini! https://lnkd.in/gs7DUMpJ

Novo Nordisk’s Jacob Petersen, Head of Global Nucleic Acid Therapies, explains how our R&D Hub taps into all the rich #Boston life science ecosystem has to offer, including unparalleled access to potential partnerships, community resources, and talent. Learn more about how we are tapping into these diverse opportunities to bring #innovation to a new level: https://bit.ly/3Os1hi4 #NovoNordiskUS

💡 What non-parenchymal cell types are present in the liver? Let's refresh the basics: check this carousel out! 🔵 Find the complete info in our latest blog: https://lnkd.in/dyYGvA-h #nonparenchymalcells #livercells #cellculture #BeCytesBiotechnologies

Publication Spotlight! 💡 "The demand for therapeutically potent hMSCs and the derived EVs has risen, highlighting the need for xeno-free bioreactor culture systems that can deliver high cell densities without compromising inherent hMSC properties" Our latest #ScienceDirect publication dives deeper into microcarrier-based hMSC expansion using the PBS Mini Vertical Wheel Bioreactor. Access the full publication here: https://hubs.li/Q02-sl6Y0 #ScaleUp #MSCs #CellTherapy

🧬 The cell membrane is the gatekeeper of the cell, controlling what goes in and out to keep it healthy and functioning! Learn more here: https://turito.me/3RmXG7G #CellMembrane #turitolearn #learningturito #learnfromturito #onlinelearning #onlinetutoring #learnonline 

In this video, Dr. Brian Sworder discusses the objective, methodology, and key results for one of the studies presented at the American Society of Hematology (#ASH) Annual Conference in 2023. The study shows the #utility of our proprietary technology, PhasED-Seq™ #MRD, vs. PET/CT to predict response following #curative intent induction #therapy in patients with diffuse large B-cell lymphoma (#DLBCL). #ForesightDx's ultra-sensitive liquid biopsy platform, Foresight CLARITY™ , is powered by PhasED-Seq™. Watch video here: https://t.ly/tyKgX Learn more about Foresight CLARITY here: https://t.ly/UnwGW #ForesightCLARITY #PhasEDseq #ctDNA #MRD #PrecisionMedicine #LiquidBiopsy